3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
NIH
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
CNS
1
Conditions
Breast Neoplasms
4
Sarcoma
2
Neoplasms, Plasma Cell
2
Myelodysplastic Syndromes
2
Multiple Myeloma
2
Squamous Cell Carcinoma of Head and Neck
1
Radiation Pneumonitis
1
Radiation Injuries
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Myelodysplastic-Myeloproliferative Diseases
1
Lymphoma
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
1
Leukemia, Myeloid, Acute
1
Leukemia, Myeloid
1
Hodgkin Disease
1
Head and Neck Neoplasms
1
Gliosarcoma
1
Glioblastoma
1
Flap Necrosis
1
Fibrosis
1
Carcinoma, Squamous Cell
1
Carcinoma, Hepatocellular
1
Interventions
Temozolomide
85
Radiotherapy
51
Bevacizumab
31
Irinotecan
19
Radiation
16
Carmustine
15
Magnetic Resonance Spectroscopy
14
Erlotinib Hydrochloride
14
O(6)-benzylguanine
11
Chemotherapy, Adjuvant
11
Carboplatin
9
sargramostim
8
Thalidomide
8
Imatinib Mesylate
8
Filgrastim
8
Surgical Procedures, Operative
6
Gene Expression Profiling
6
Drug Therapy
6
pembrolizumab
5
aldesleukin
5
Topotecan
5
Radiotherapy, Intensity-Modulated
5
Hydroxyurea
5
Gefitinib
5
Etoposide
5
Sorafenib
4
Immunohistochemistry
4
Dasatinib
4
Celecoxib
4
Biopsy
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Gliosarcoma
×
Hyperbaric Oxygenation
×
Clear all
NCT00936052
2010-07-16
HBO
Neurological Surgery, P.C.
Phase 2
Unknown
20 enrolled